Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 9—September 2020
Research

Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012

Lauren C. RamsayComments to Author , Emily Shing, John Wang, Theodore K. Marras, Jeffrey C. Kwong, Sarah K. Brode, Frances B. Jamieson, and Beate Sander
Author affiliations: University Health Network, Toronto, Ontario, Canada (L.C. Ramsay, T.K. Marras, J.C. Kwong, S.K. Brode, B. Sander); University of Toronto, Toronto (L.C. Ramsay, T.K. Marras, J.C. Kwong, S.K. Brode, F.B. Jamieson, B. Sander); Public Health Ontario, Toronto (E. Shing, J. Wang, J.C. Kwong, F.B. Jamieson, B. Sander); ICES, Toronto (J. Wang, J.C. Kwong, S.K. Brode, B. Sander); West Park Healthcare Centre, Toronto (S.K. Brode)

Main Article

Figure 1

Ten-day mean attributable costs for nontuberculous mycobacterial pulmonary disease patients by phase, stratified by age, Ontario, Canada, 2001–2012. Number of patients per category: initial infection, 6,906; subsequent care, 6,906; continuous care, 6,489; before death, 2,835.

Figure 1. Ten-day mean attributable costs for nontuberculous mycobacterial pulmonary disease patients by phase, stratified by age, Ontario, Canada, 2001–2012. Number of patients per category: initial infection, 6,906; subsequent care, 6,906; continuous care, 6,489; before death, 2,835.

Main Article

Page created: July 10, 2020
Page updated: August 18, 2020
Page reviewed: August 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external